• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Aon Hewitt establishes a healthcare exchange for corporate clients

Article

Aon Hewitt, the human resource consulting and outsourcing business of Aon Corporation, plans to offer a corporate healthcare exchange to employers nationwide, targeting 1,000 or more full-time employees, beginning as early as 2012.

Aon Hewitt, the human resource consulting and outsourcing business of Aon Corporation, plans to offer a corporate healthcare exchange to employers nationwide, targeting 1,000 or more full-time employees, beginning as early as 2012.

Aon Hewitt has been providing and administering retiree medical exchanges for several years. The Aon Hewitt exchange model is an extension of its retiree medical exchange, which administers retiree benefits to more than 2.4 million participants. In anticipation of changes to the insurance market, the organization is extending its exchange model to offer employers a viable option for active employees.

The company is conducting healthcare conferences for their clients in many cities. At the Chicago and New York events, 243 participants were asked about their plans to provide healthcare coverage to their employees in 2015 and beyond. There was a nearly even split between employers who thought they would ultimately be delivering health benefits via a corporate exchange (43%) vs. continuing to offer healthcare benefits directly with greater financial controls and policies (47%).  Meanwhile, 9% said they would continue their attempts to manage the healthcare trend annually, based on current business and economic conditions, and 1% said they do not believe they would be offering healthcare coverage at all in 2015.  

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.